Aller au contenu principal
Profil bibliographique

Quentin Balacheff

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées
42Citations signalées
5Affiliations récentes

Les institutions déclarées

Les domaines associés

Bacteriophages and microbial interactionsAntibiotic Resistance in BacteriaRespiratory viral infections researchPneumonia and Respiratory InfectionsCRISPR and Genetic Engineering

Les publications récentes

Accès ouvert 2025 article OpenAlex

Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy

Sophia Zborowsky, Jérémy Seurat, Quentin Balacheff, Solène Ecomard et autres

The rise of antimicrobial resistance leads to renewed interest in evaluating phage therapy. In murine models highly effective treatment of acute pneumonia caused by Pseudomonas aeruginosa relies on the synergistic antibacterial activity of bacteriophages with neutrophils. Here, we show that depletion of …

fr, us, re (code pays fourni par la source)

24 citations Nature Communications
Accès ouvert 2024 article OpenAlex

Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection

Rogelio A. Rodriguez-Gonzalez, Quentin Balacheff, Laurent Debarbieux, Jacopo Marchi et autres

ABSTRACT Infections caused by multidrug resistant (MDR) pathogenic bacteria are a global health threat. Bacteriophages (“phage”) are increasingly used as alternative or last-resort therapeutics to treat patients infected by MDR bacteria. However, the therapeutic outcomes of phage therapy may be limited by …

us, re, fr (code pays fourni par la source)

5 citations mSystems
Accès ouvert 2024 preprint OpenAlex

Metapopulation model of phage therapy of an acute Pseudomonas aeruginosa lung infection

Rogelio A. Rodriguez-Gonzalez, Quentin Balacheff, Laurent Debarbieux, Jacopo Marchi et autres

Infections caused by multi-drug resistant (MDR) pathogenic bacteria are a global health threat. Phage therapy, which uses phage to kill bacterial pathogens, is increasingly used to treat patients infected by MDR bacteria. However, the therapeutic outcome of phage therapy may be limited …

us, re, fr (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 preprint OpenAlex

Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy

Sophia Zborowsky, Jérémy Seurat, Quentin Balacheff, Solène Ecomard et autres

Abstract The rise of antimicrobial resistance has led to renewed interest in evaluating phage therapy. In murine models highly effective treatment of acute pneumonia caused by Pseudomonas aeruginosa relies on the synergistic antibacterial activity of bacteriophages with neutrophils. Here, we show that …

fr, us, re (code pays fourni par la source)

6 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 article OpenAlex

A nanoluciferase-encoded bacteriophage illuminates viral infection dynamics of Pseudomonas aeruginosa cells

Sophia Zborowsky, Quentin Balacheff, Ioanna Théodorou, Rokhaya Kane et autres

Abstract Bacteriophages (phages) are increasingly considered for both treatment and early detection of bacterial pathogens given their specificity and rapid infection kinetics. Here, we exploit an engineered phage expressing nanoluciferase to detect signals associated with Pseudomonas aeruginosa lysis spanning single cells to …

fr, us (code pays fourni par la source)

2 citations ISME Communications
2021 article OpenAlex

Splenic abscess caused by Toxocara spp. in a lung transplant recipient, Marseille, France

Quentin Balacheff, Jean‐Baptiste Lovato, Benjamin Coiffard, Coralie L’Ollivier et autres

Infections represent one of the leading causes of morbidity and mortality in solid organ transplantation (SOT) recipients. Although Toxocara species are prevalent worldwide, toxocariasis is an important neglected human disease that can manifest as visceral or ocular larva migrans, or covert toxocariasis. …

fr (code pays fourni par la source)

4 citations Transplant Infectious Disease

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.